Liver X receptor is a therapeutic target in collagen-induced arthritis.
Chintalacharuvu
Subba R
SR
Eli Lilly and Company, Indianapolis, IN, USA.
Sandusky
George E
GE
Burris
Thomas P
TP
Burmer
Glenna C
GC
Nagpal
Sunil
S
D000818:Animals; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001169:Arthritis, Experimental / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006845:Hydrocarbons, Fluorinated; D008070:Lipopolysaccharides / Q000494:pharmacology; D000071518:Liver X Receptors; D051379:Mice; D008807:Mice, Inbred BALB C; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D013449:Sulfonamides / Q000627:therapeutic use*; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D005466:Fluorocarbons; D000096926:Benzenesulfonamides
D018501:Antirheumatic Agents; D016207:Cytokines; D004268:DNA-Binding Proteins; D006845:Hydrocarbons, Fluorinated; D008070:Lipopolysaccharides; D000071518:Liver X Receptors; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear; D013449:Sulfonamides; C423915:T0901317; D005466:Fluorocarbons; D000096926:Benzenesulfonamides